2014 Q3 Form 10-K Financial Statement
#000117891314002913 Filed on September 11, 2014
Income Statement
| Concept | 2014 Q3 | 2014 | 2013 Q2 |
|---|---|---|---|
| Revenue | $95.00K | $379.0K | $100.0K |
| YoY Change | 0.0% | -44.18% | -0.99% |
| Cost Of Revenue | $3.000K | $11.00K | $0.00 |
| YoY Change | 0.0% | -45.0% | |
| Gross Profit | $92.00K | $368.0K | $90.00K |
| YoY Change | 0.0% | -44.16% | -10.89% |
| Gross Profit Margin | 96.84% | 97.1% | 90.0% |
| Selling, General & Admin | $1.680M | $8.680M | $1.390M |
| YoY Change | -8.2% | 53.63% | -19.65% |
| % of Gross Profit | 1826.09% | 2358.7% | 1544.44% |
| Research & Development | $24.94M | ||
| YoY Change | 25.28% | ||
| % of Gross Profit | 6776.63% | ||
| Depreciation & Amortization | $498.0K | $1.902M | $440.0K |
| YoY Change | 8.03% | 84.12% | 238.46% |
| % of Gross Profit | 541.3% | 516.85% | 488.89% |
| Operating Expenses | $5.720M | $24.94M | $7.310M |
| YoY Change | 15.51% | 25.28% | 79.52% |
| Operating Profit | -$5.623M | -$27.85M | -$7.220M |
| YoY Change | 15.7% | 25.32% | 81.82% |
| Interest Expense | $200.0K | $950.0K | $230.0K |
| YoY Change | 81.82% | -13.64% | -243.75% |
| % of Operating Profit | |||
| Other Income/Expense, Net | -$288.0K | $918.0K | |
| YoY Change | -374.29% | -14.04% | |
| Pretax Income | -$5.910M | -$26.93M | -$6.990M |
| YoY Change | 24.16% | 27.27% | 68.84% |
| Income Tax | $0.00 | $0.00 | |
| % Of Pretax Income | |||
| Net Earnings | -$5.911M | -$26.93M | -$6.990M |
| YoY Change | 24.31% | 27.31% | 69.04% |
| Net Earnings / Revenue | -6222.11% | -7106.07% | -6990.0% |
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$0.86 | -$4.241M | -$1.20 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 69.28M shares | 58.64M shares | |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2014 Q3 | 2014 | 2013 Q2 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $46.05M | $53.91M | $53.90M |
| YoY Change | -5.38% | 0.02% | 42.55% |
| Cash & Equivalents | $5.662M | $4.490M | $9.007M |
| Short-Term Investments | $40.39M | $49.41M | $44.89M |
| Other Short-Term Assets | $704.0K | $5.820M | $599.0K |
| YoY Change | -76.91% | 389.08% | 56.4% |
| Inventory | |||
| Prepaid Expenses | |||
| Receivables | $451.0K | $2.260M | $273.0K |
| Other Receivables | $0.00 | $0.00 | |
| Total Short-Term Assets | $52.29M | $61.99M | $55.09M |
| YoY Change | -0.34% | 12.52% | 44.23% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $10.54M | $10.82M | $11.87M |
| YoY Change | -9.62% | -8.85% | 136.42% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | $290.0K | $300.0K | $420.0K |
| YoY Change | -6.45% | -28.57% | -67.44% |
| Other Assets | $2.000K | $910.0K | $39.00K |
| YoY Change | -90.48% | -3.19% | |
| Total Long-Term Assets | $11.54M | $12.03M | $13.23M |
| YoY Change | -11.35% | -9.07% | 43.38% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $52.29M | $61.99M | $55.09M |
| Total Long-Term Assets | $11.54M | $12.03M | $13.23M |
| Total Assets | $63.83M | $74.02M | $68.32M |
| YoY Change | -2.52% | 8.34% | 44.07% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $2.421M | $3.470M | $2.837M |
| YoY Change | -15.94% | 22.18% | 107.38% |
| Accrued Expenses | $1.003M | $2.310M | $1.040M |
| YoY Change | 0.0% | 4.05% | 12.8% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $5.985M | $7.400M | $5.921M |
| YoY Change | 4.43% | 25.0% | 7.23% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Other Long-Term Liabilities | $566.0K | $4.500M | $680.0K |
| YoY Change | -13.85% | -8.72% | |
| Total Long-Term Liabilities | $4.150M | $4.500M | $4.929M |
| YoY Change | -16.35% | -8.72% | 18.6% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $5.985M | $7.400M | $5.921M |
| Total Long-Term Liabilities | $4.150M | $4.500M | $4.929M |
| Total Liabilities | $10.14M | $11.90M | $10.85M |
| YoY Change | -5.21% | 9.68% | 12.11% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$119.7M | -$86.90M | |
| YoY Change | 30.64% | 32.18% | |
| Common Stock | $0.00 | $0.00 | |
| YoY Change | |||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $53.70M | $62.12M | $57.47M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $63.83M | $74.02M | $68.32M |
| YoY Change | -2.52% | 8.34% | 44.07% |
Cashflow Statement
| Concept | 2014 Q3 | 2014 | 2013 Q2 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$5.911M | -$26.93M | -$6.990M |
| YoY Change | 24.31% | 27.31% | 69.04% |
| Depreciation, Depletion And Amortization | $498.0K | $1.902M | $440.0K |
| YoY Change | 8.03% | 84.12% | 238.46% |
| Cash From Operating Activities | -$3.460M | -$19.12M | -$5.020M |
| YoY Change | -32.09% | 13.22% | 439.78% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $271.0K | $1.573M | $1.060M |
| YoY Change | -41.34% | -63.5% | 523.53% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $4.790M | $3.560M | -$13.08M |
| YoY Change | 159566.67% | -122.98% | 861.76% |
| Cash From Investing Activities | $4.520M | $1.980M | -$14.14M |
| YoY Change | 8.08% | -110.0% | 830.26% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $10.64M | ||
| YoY Change | -68.79% | ||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 110.0K | 12.62M | 330.0K |
| YoY Change | -78.39% | -65.24% | 43.48% |
| NET CHANGE | |||
| Cash From Operating Activities | -3.460M | -19.12M | -5.020M |
| Cash From Investing Activities | 4.520M | 1.980M | -14.14M |
| Cash From Financing Activities | 110.0K | 12.62M | 330.0K |
| Net Change In Cash | 1.170M | -4.520M | -18.83M |
| YoY Change | -389.6% | 1083.25% | 748.2% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$3.460M | -$19.12M | -$5.020M |
| Capital Expenditures | $271.0K | $1.573M | $1.060M |
| Free Cash Flow | -$3.731M | -$20.69M | -$6.080M |
| YoY Change | -32.86% | -2.37% | 452.73% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2014 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2014Q2 | psti |
Available For Sale Marketable Securities Number
AvailableForSaleMarketableSecuritiesNumber
|
1011504 | shares |
| CY2014 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--06-30 | |
| CY2014 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
| CY2014 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2014 | |
| CY2014 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2014-06-30 | |
| CY2014 | dei |
Document Type
DocumentType
|
10-K | |
| CY2014 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001158780 | |
| CY2014Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
69278512 | shares |
| CY2014 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2014 | dei |
Entity Filer Category
EntityFilerCategory
|
Accelerated Filer | |
| CY2013Q4 | dei |
Entity Public Float
EntityPublicFloat
|
214202402 | USD |
| CY2014 | dei |
Entity Registrant Name
EntityRegistrantName
|
PLURISTEM THERAPEUTICS INC | |
| CY2014 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
| CY2014 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
| CY2014 | psti |
Advance Payment For Deveploment Costs
AdvancePaymentForDeveplomentCosts
|
2000000 | USD |
| CY2014Q2 | psti |
Aggregate Grants Received
AggregateGrantsReceived
|
14125000 | USD |
| CY2014 | psti |
Amortization Of Discount And Premium And Changes In Accrued Interest From Marketable Securities
AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities
|
1282000 | USD |
| CY2013 | psti |
Amortization Of Discount And Premium And Changes In Accrued Interest From Marketable Securities
AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities
|
154000 | USD |
| CY2012 | psti |
Amortization Of Discount And Premium And Changes In Accrued Interest From Marketable Securities
AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities
|
17000 | USD |
| CY2014 | psti |
Business Combination Contingent Consideration Receivable Upon Certain Regulatory Milestones
BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones
|
37500000 | USD |
| CY2014 | psti |
Government And Third Party Grants Received
GovernmentAndThirdPartyGrantsReceived
|
5396000 | USD |
| CY2013 | psti |
Government And Third Party Grants Received
GovernmentAndThirdPartyGrantsReceived
|
2673000 | USD |
| CY2012 | psti |
Government And Third Party Grants Received
GovernmentAndThirdPartyGrantsReceived
|
3527000 | USD |
| CY2014 | psti |
Interest On Short Term Bank Credit And Bank Expenses
InterestOnShortTermBankCreditAndBankExpenses
|
36000 | USD |
| CY2013 | psti |
Interest On Short Term Bank Credit And Bank Expenses
InterestOnShortTermBankCreditAndBankExpenses
|
29000 | USD |
| CY2012 | psti |
Interest On Short Term Bank Credit And Bank Expenses
InterestOnShortTermBankCreditAndBankExpenses
|
12000 | USD |
| CY2014 | psti |
Linkage Differences And Interest On Short And Long Term Restricted Lease Deposit
LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit
|
12000 | USD |
| CY2013 | psti |
Linkage Differences And Interest On Short And Long Term Restricted Lease Deposit
LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit
|
-30000 | USD |
| CY2012 | psti |
Linkage Differences And Interest On Short And Long Term Restricted Lease Deposit
LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit
|
35000 | USD |
| CY2014 | psti |
Warrants And Options Weighted Average Remaining Contractual Term Exercisable
WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable
|
P3Y11M5D | |
| CY2014 | psti |
Warrants And Options Weighted Average Remaining Contractual Term Vested And Expected To Vest
WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest
|
P3Y11M16D | |
| CY2014Q2 | psti |
Other Accounts Payable Payroll Institutions
OtherAccountsPayablePayrollInstitutions
|
302000 | USD |
| CY2013Q2 | psti |
Other Accounts Payable Payroll Institutions
OtherAccountsPayablePayrollInstitutions
|
324000 | USD |
| CY2014 | psti |
Percentage Of Qualified Expenditures
PercentageOfQualifiedExpenditures
|
0.5 | pure |
| CY2014Q2 | psti |
Reclass From Research And Development Expense To Cost Of Revenues
ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues
|
1753000 | USD |
| CY2014 | psti |
Remaining Deferred Revenue Recognition Period For Intangible Asset
RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset
|
P8Y6M | |
| CY2014 | psti |
Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
|
19542000 | USD |
| CY2013 | psti |
Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
|
17233000 | USD |
| CY2012 | psti |
Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
|
9158000 | USD |
| CY2014 | psti |
Research And Development Milestone Revenue Receivable
ResearchAndDevelopmentMilestoneRevenueReceivable
|
37500000 | USD |
| CY2014Q2 | psti |
Royalties Amount Paid And Accrued
RoyaltiesAmountPaidAndAccrued
|
53000 | USD |
| CY2014 | psti |
Royalty Rate Payable On Grants Received
RoyaltyRatePayableOnGrantsReceived
|
1 | pure |
| CY2014 | psti |
Sharebased Goods And Nonemployees Services Transaction Warrants And Options Exercised
SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised
|
66500 | shares |
| CY2014 | psti |
Sharebased Goods And Nonemployees Services Transaction Warrants And Options Granted
SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted
|
3000 | shares |
| CY2014Q2 | psti |
Sharebased Goods And Nonemployees Services Transaction Warrants And Options Number
SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber
|
252000 | shares |
| CY2013Q2 | psti |
Sharebased Goods And Nonemployees Services Transaction Warrants And Options Number
SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber
|
315500 | shares |
| CY2014Q2 | psti |
Sharebased Goods And Nonemployees Services Transaction Warrants And Options Number Exercisable
SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable
|
251000 | shares |
| CY2014Q2 | psti |
Sharebased Goods And Nonemployees Services Transaction Warrants And Options Number Vested And Expected To Vest
SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest
|
252000 | shares |
| CY2014 | psti |
Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
|
12000 | USD |
| CY2013 | psti |
Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
|
176000 | USD |
| CY2012 | psti |
Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
|
89000 | USD |
| CY2014 | psti |
Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
|
1968000 | USD |
| CY2013 | psti |
Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
|
2009000 | USD |
| CY2012 | psti |
Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
|
556000 | USD |
| CY2014Q2 | psti |
Warrants And Options Aggregate Intrinsic Value
WarrantsAndOptionsAggregateIntrinsicValue
|
331000 | USD |
| CY2014Q2 | psti |
Warrants And Options Aggregate Intrinsic Value Exercisable
WarrantsAndOptionsAggregateIntrinsicValueExercisable
|
328000 | USD |
| CY2014Q2 | psti |
Warrants And Options Aggregate Intrinsic Value Vested And Expected To Vest
WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest
|
331000 | USD |
| CY2014 | psti |
Warrants And Options Exercised Weighted Average Exercise Price
WarrantsAndOptionsExercisedWeightedAverageExercisePrice
|
1.39 | |
| CY2014 | psti |
Warrants And Options Granted Weighted Average Exercise Price
WarrantsAndOptionsGrantedWeightedAverageExercisePrice
|
0.00 | |
| CY2014Q2 | psti |
Warrants And Options Weighted Average Exercise Price
WarrantsAndOptionsWeightedAverageExercisePrice
|
5.19 | |
| CY2013Q2 | psti |
Warrants And Options Weighted Average Exercise Price
WarrantsAndOptionsWeightedAverageExercisePrice
|
4.44 | |
| CY2014Q2 | psti |
Warrants And Options Weighted Average Exercise Price Excercisable
WarrantsAndOptionsWeightedAverageExercisePriceExcercisable
|
5.21 | |
| CY2014Q2 | psti |
Warrants And Options Weighted Average Exercise Price Vested And Expected To Vest
WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest
|
5.19 | |
| CY2014 | psti |
Warrants And Options Weighted Average Remaining Contractual Term
WarrantsAndOptionsWeightedAverageRemainingContractualTerm
|
P3Y11M16D | |
| CY2014Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
3465000 | USD |
| CY2013Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
2837000 | USD |
| CY2014Q2 | us-gaap |
Accounts Payable Other Current
AccountsPayableOtherCurrent
|
2391000 | USD |
| CY2013Q2 | us-gaap |
Accounts Payable Other Current
AccountsPayableOtherCurrent
|
1272000 | USD |
| CY2014Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
2263000 | USD |
| CY2013Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
273000 | USD |
| CY2014Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
915000 | USD |
| CY2013Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1040000 | USD |
| CY2014Q2 | us-gaap |
Accrued Vacation Current
AccruedVacationCurrent
|
673000 | USD |
| CY2013Q2 | us-gaap |
Accrued Vacation Current
AccruedVacationCurrent
|
506000 | USD |
| CY2014Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
4132000 | USD |
| CY2013Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2349000 | USD |
| CY2014Q2 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
2959000 | USD |
| CY2013Q2 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
259000 | USD |
| CY2014Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
172998000 | USD |
| CY2013Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
144109000 | USD |
| CY2014 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
195000 | USD |
| CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
2694000 | USD |
| CY2014Q2 | us-gaap |
Assets
Assets
|
74023000 | USD |
| CY2013Q2 | us-gaap |
Assets
Assets
|
68316000 | USD |
| CY2014Q2 | us-gaap |
Assets Current
AssetsCurrent
|
61987000 | USD |
| CY2013Q2 | us-gaap |
Assets Current
AssetsCurrent
|
55085000 | USD |
| CY2014Q2 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
12036000 | USD |
| CY2013Q2 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
13231000 | USD |
| CY2014Q2 | us-gaap |
Available For Sale Equity Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
2965000 | USD |
| CY2013Q2 | us-gaap |
Available For Sale Equity Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
570000 | USD |
| CY2014Q2 | us-gaap |
Available For Sale Equity Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
29000 | USD |
| CY2013Q2 | us-gaap |
Available For Sale Equity Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
311000 | USD |
| CY2014Q2 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
29961000 | USD |
| CY2013Q2 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
13441000 | USD |
| CY2014Q2 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
27025000 | USD |
| CY2013Q2 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
13182000 | USD |
| CY2014Q2 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
12000 | USD |
| CY2013Q2 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
9000 | USD |
| CY2014Q2 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
17000 | USD |
| CY2013Q2 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
302000 | USD |
| CY2014Q2 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
|
851000 | USD |
| CY2013Q2 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
|
5122000 | USD |
| CY2014Q2 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
|
463000 | USD |
| CY2013Q2 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
|
32000 | USD |
| CY2014 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
243000 | USD |
| CY2013 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
872000 | USD |
| CY2012 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
738000 | USD |
| CY2014Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
4493000 | USD |
| CY2013Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
9007000 | USD |
| CY2011Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
42829000 | USD |
| CY2012Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
9389000 | USD |
| CY2014 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-4514000 | USD |
| CY2013 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-382000 | USD |
| CY2012 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-33440000 | USD |
| CY2014Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2013Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2014Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.00001 | |
| CY2013Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.00001 | |
| CY2014Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
| CY2013Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
| CY2014Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
68601452 | shares |
| CY2013Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
59196617 | shares |
| CY2014Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
68601452 | shares |
| CY2013Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
59196617 | shares |
| CY2014Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
USD | |
| CY2013Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
USD | |
| CY2014 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-24232000 | USD |
| CY2013 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-20766000 | USD |
| CY2012 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-14924000 | USD |
| CY2014 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> p.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Concentration of credit risk</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> </div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, short-term deposits, long-term deposits, restricted deposits and marketable securities.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> </div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The majority of the Company's cash and cash equivalents and short-term and long-term deposits are invested in dollar instruments of major banks in Israel. Generally, these deposits may be redeemed upon demand and therefore bear minimal risk.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> </div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The Company invests its surplus cash in cash deposits and marketable securities in financial institutions and has established guidelines, approved by the Company's Investment Committee, relating to diversification and maturities to maintain safety and liquidity of the investments.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> </div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The Company holds an investment portfolio consisting of corporate bonds, government bonds, stocks and index linked notes. The Company intends, and has the ability, to hold such investments until recovery of temporary declines in market value or maturity; accordingly, as of June 30, 2014, the Company believes the losses associated with its investments are temporary and no impairment loss was recognized during 2014. However, the Company can provide no assurance that it will recover declines in the market value of its investments.</div> </td> </tr> </table> </div> <!--EndFragment--></div> </div> | |
| CY2014 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
11000 | USD |
| CY2013 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
20000 | USD |
| CY2012 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
21000 | USD |
| CY2014Q2 | us-gaap |
Customer Advances Current
CustomerAdvancesCurrent
|
247000 | USD |
| CY2013Q2 | us-gaap |
Customer Advances Current
CustomerAdvancesCurrent
|
393000 | USD |
| CY2014Q2 | us-gaap |
Deferred Rent Credit Current
DeferredRentCreditCurrent
|
89000 | USD |
| CY2013Q2 | us-gaap |
Deferred Rent Credit Current
DeferredRentCreditCurrent
|
89000 | USD |
| CY2014 | us-gaap |
Deferred Revenue Additions
DeferredRevenueAdditions
|
5000000 | USD |
| CY2014Q2 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
379000 | USD |
| CY2013Q2 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
379000 | USD |
| CY2014Q2 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
2847000 | USD |
| CY2013Q2 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
3226000 | USD |
| CY2014Q2 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
21002000 | USD |
| CY2013Q2 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
15805000 | USD |
| CY2014Q2 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
USD | |
| CY2013Q2 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
USD | |
| CY2014Q2 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
7955000 | USD |
| CY2013Q2 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
7106000 | USD |
| CY2014Q2 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
|
12810000 | USD |
| CY2013Q2 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
|
8543000 | USD |
| CY2014Q2 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
|
237000 | USD |
| CY2013Q2 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
|
156000 | USD |
| CY2014Q2 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
21002000 | USD |
| CY2013Q2 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
15805000 | USD |
| CY2014Q2 | us-gaap |
Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
|
901000 | USD |
| CY2013Q2 | us-gaap |
Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
|
905000 | USD |
| CY2014 | us-gaap |
Depreciation
Depreciation
|
1902000 | USD |
| CY2013 | us-gaap |
Depreciation
Depreciation
|
1033000 | USD |
| CY2012 | us-gaap |
Depreciation
Depreciation
|
435000 | USD |
| CY2014Q2 | us-gaap |
Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
|
-842000 | USD |
| CY2013Q2 | us-gaap |
Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
|
93000 | USD |
| CY2014 | us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
-83000 | USD |
| CY2013 | us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
140000 | USD |
| CY2012 | us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
-317000 | USD |
| CY2014Q2 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
889000 | USD |
| CY2013Q2 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
USD | |
| CY2014 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.42 | |
| CY2013 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.38 | |
| CY2012 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.34 | |
| CY2014 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
| CY2012 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
| CY2014Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
424000 | USD |
| CY2013Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
353000 | USD |
| CY2014 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
407000 | USD |
| CY2013 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
497000 | USD |
| CY2012 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-98000 | USD |
| CY2014 | us-gaap |
Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
|
-70000 | USD |
| CY2013 | us-gaap |
Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
|
231000 | USD |
| CY2012 | us-gaap |
Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
|
-145000 | USD |
| CY2014 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-85000 | USD |
| CY2013 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
USD | |
| CY2012 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-1000 | USD |
| CY2014 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
8676000 | USD |
| CY2013 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
5649000 | USD |
| CY2012 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
6568000 | USD |
| CY2014 | us-gaap |
Gross Profit
GrossProfit
|
368000 | USD |
| CY2013 | us-gaap |
Gross Profit
GrossProfit
|
659000 | USD |
| CY2012 | us-gaap |
Gross Profit
GrossProfit
|
695000 | USD |
| CY2014 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
48000 | USD |
| CY2013 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
18000 | USD |
| CY2012 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
14000 | USD |
| CY2014 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
1257000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
1335000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-424000 | USD |
| CY2014 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
143000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
233000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-64000 | USD |
| CY2014 | us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
36000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
140000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
395000 | USD |
| CY2014 | us-gaap |
Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
|
-146000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
|
-1183000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
|
1576000 | USD |
| CY2014 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-379000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-679000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
4284000 | USD |
| CY2014 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
902000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
1556000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
958000 | USD |
| CY2014 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
1990000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
70000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
230000 | USD |
| CY2014 | us-gaap |
Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
|
49000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
|
-11000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
|
5000 | USD |
| CY2014 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
108000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
237000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-269000 | USD |
| CY2014 | us-gaap |
Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
|
-122000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
|
-869000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
|
-6000 | USD |
| CY2014 | us-gaap |
Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
|
246000 | USD |
| CY2013 | us-gaap |
Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
|
539000 | USD |
| CY2012 | us-gaap |
Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
|
575000 | USD |
| CY2014Q2 | us-gaap |
Interest Receivable
InterestReceivable
|
98000 | USD |
| CY2013Q2 | us-gaap |
Interest Receivable
InterestReceivable
|
20000 | USD |
| CY2014Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
74023000 | USD |
| CY2013Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
68316000 | USD |
| CY2014Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
7397000 | USD |
| CY2013Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
5921000 | USD |
| CY2014Q2 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
4503000 | USD |
| CY2013Q2 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
4929000 | USD |
| CY2011Q3 | us-gaap |
Licenses Revenue
LicensesRevenue
|
7000000 | USD |
| CY2014Q2 | us-gaap |
Long Term Investments
LongTermInvestments
|
304000 | USD |
| CY2013Q2 | us-gaap |
Long Term Investments
LongTermInvestments
|
421000 | USD |
| CY2014Q2 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
29961000 | USD |
| CY2013Q2 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
13441000 | USD |
| CY2014 | us-gaap |
Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
|
384000 | USD |
| CY2013 | us-gaap |
Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
|
-79000 | USD |
| CY2012 | us-gaap |
Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
|
89000 | USD |
| CY2014 | us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
727000 | USD |
| CY2013 | us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
26000 | USD |
| CY2012 | us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
3000 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
12624000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
36304000 | USD |
| CY2012 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
632000 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
1983000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-19799000 | USD |
| CY2012 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-30797000 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-19121000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-16887000 | USD |
| CY2012 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-3275000 | USD |
| CY2014 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-26932000 | USD |
| CY2013 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-21155000 | USD |
| CY2012 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-14794000 | USD |
| CY2013 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
|
26000 | USD |
| CY2012 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
|
3000 | USD |
| CY2014 | us-gaap |
Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
|
23000 | USD |
| CY2013 | us-gaap |
Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
|
USD | |
| CY2014 | us-gaap |
Noncash Or Part Noncash Acquisition Investments Acquired1
NoncashOrPartNoncashAcquisitionInvestmentsAcquired1
|
10414000 | USD |
| CY2013 | us-gaap |
Noncash Or Part Noncash Acquisition Investments Acquired1
NoncashOrPartNoncashAcquisitionInvestmentsAcquired1
|
USD | |
| CY2012 | us-gaap |
Noncash Or Part Noncash Acquisition Investments Acquired1
NoncashOrPartNoncashAcquisitionInvestmentsAcquired1
|
USD | |
| CY2014 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
918000 | USD |
| CY2013 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
1068000 | USD |
| CY2012 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
237000 | USD |
| CY2014 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-27850000 | USD |
| CY2013 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-22223000 | USD |
| CY2012 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-15031000 | USD |
| CY2014Q2 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
14000 | USD |
| CY2013Q2 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
USD | |
| CY2014Q2 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
905000 | USD |
| CY2013Q2 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
599000 | USD |
| CY2014Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
8000 | USD |
| CY2013Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
39000 | USD |
| CY2014 | us-gaap |
Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
|
3427000 | USD |
| CY2014 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
2700000 | USD |
| CY2013 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
389000 | USD |
| CY2012 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-130000 | USD |
| CY2014 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
|
727000 | USD |
| CY2012 | us-gaap |
Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
|
USD | |
| CY2012Q3 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
34106000 | USD |
| CY2014 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
1980000 | USD |
| CY2013 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
2198000 | USD |
| CY2014 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
3404000 | USD |
| CY2013 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
415000 | USD |
| CY2012 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-127000 | USD |
| CY2014Q2 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
588000 | USD |
| CY2013Q2 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
680000 | USD |
| CY2014 | us-gaap |
Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
|
USD | |
| CY2013 | us-gaap |
Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
|
USD | |
| CY2012 | us-gaap |
Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
|
13000 | USD |
| CY2014 | us-gaap |
Payments For Proceeds From Longterm Investments
PaymentsForProceedsFromLongtermInvestments
|
3000 | USD |
| CY2013 | us-gaap |
Payments For Proceeds From Longterm Investments
PaymentsForProceedsFromLongtermInvestments
|
USD | |
| CY2012 | us-gaap |
Payments For Proceeds From Longterm Investments
PaymentsForProceedsFromLongtermInvestments
|
1125000 | USD |
| CY2014 | us-gaap |
Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
|
-7421000 | USD |
| CY2013 | us-gaap |
Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
|
10202000 | USD |
| CY2012 | us-gaap |
Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
|
21031000 | USD |
| CY2014 | us-gaap |
Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
|
10851000 | USD |
| CY2013 | us-gaap |
Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
|
8534000 | USD |
| CY2012 | us-gaap |
Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
|
8165000 | USD |
| CY2014 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1573000 | USD |
| CY2013 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
4309000 | USD |
| CY2012 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1480000 | USD |
| CY2014Q2 | us-gaap |
Pledged Assets Not Separately Reported Other Financial Instruments
PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments
|
4805000 | USD |
| CY2014Q2 | us-gaap |
Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
|
1068000 | USD |
| CY2013Q2 | us-gaap |
Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
|
1023000 | USD |
| CY2014 | us-gaap |
Postemployment Benefits Period Expense
PostemploymentBenefitsPeriodExpense
|
534000 | USD |
| CY2013 | us-gaap |
Postemployment Benefits Period Expense
PostemploymentBenefitsPeriodExpense
|
329000 | USD |
| CY2012 | us-gaap |
Postemployment Benefits Period Expense
PostemploymentBenefitsPeriodExpense
|
275000 | USD |
| CY2014Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.00001 | |
| CY2014Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
| CY2011Q3 | us-gaap |
Proceeds From Customers
ProceedsFromCustomers
|
2000000 | USD |
| CY2014 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
10644000 | USD |
| CY2013 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
34106000 | USD |
| CY2012 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
USD | |
| CY2013 | us-gaap |
Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
|
1848000 | USD |
| CY2012 | us-gaap |
Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
|
884000 | USD |
| CY2013 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
2009000 | USD |
| CY2012 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
632000 | USD |
| CY2014 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
754000 | USD |
| CY2013 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
529000 | USD |
| CY2012 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
114000 | USD |
| CY2014 | us-gaap |
Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
|
6113000 | USD |
| CY2012 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
556000 | USD |
| CY2014Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
14955000 | USD |
| CY2013Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
14215000 | USD |
| CY2014Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
10823000 | USD |
| CY2013Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
11866000 | USD |
| CY2014 | us-gaap |
Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
|
727000 | USD |
| CY2014 | us-gaap |
Reimbursement Revenue
ReimbursementRevenue
|
10000000 | USD |
| CY2014 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
24938000 | USD |
| CY2013 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
19906000 | USD |
| CY2012 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
12685000 | USD |
| CY2014Q2 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
4914000 | USD |
| CY2013Q2 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
316000 | USD |
| CY2014Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-113834000 | USD |
| CY2013Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-86902000 | USD |
| CY2011Q3 | us-gaap |
Revenue From Grants
RevenueFromGrants
|
5000000 | USD |
| CY2013 | us-gaap |
Revenues
Revenues
|
679000 | USD |
| CY2012 | us-gaap |
Revenues
Revenues
|
716000 | USD |
| CY2014 | us-gaap |
Revenues
Revenues
|
379000 | USD |
| CY2014Q2 | us-gaap |
Royalty Guarantees Commitments Amount
RoyaltyGuaranteesCommitmentsAmount
|
14072000 | USD |
| CY2014 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
5851000 | USD |
| CY2013 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2799000 | USD |
| CY2012 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
4927000 | USD |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
3.53 | |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
3.43 | |
| CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
2.54 | |
| CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
13256713 | shares |
| CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
|
1205080 | shares |
| CY2014Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
1046000 | USD |
| CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
1862099 | shares |
| CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
3.73 | |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P3Y1M17D | |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
11.59 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
81057 | shares |
| CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
1046000 | USD |
| CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1862099 | shares |
| CY2013Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1958156 | shares |
| CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
3.73 | |
| CY2013Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.03 | |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P3Y1M17D | |
| CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
|
1046000 | USD |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
|
P3Y1M17D | |
| CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
1862099 | shares |
| CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
3.73 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.83 | |
| CY2012 | us-gaap |
Stock Issued1
StockIssued1
|
3672000 | USD |
| CY2013 | us-gaap |
Stock Issued1
StockIssued1
|
1400000 | USD |
| CY2014Q2 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
|
12647303 | shares |
| CY2014Q2 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
|
12648303 | shares |
| CY2012Q3 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
4.00 | |
| CY2014Q2 | us-gaap |
Short Term Investments
ShortTermInvestments
|
19451000 | USD |
| CY2013Q2 | us-gaap |
Short Term Investments
ShortTermInvestments
|
31449000 | USD |
| CY2014Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
62123000 | USD |
| CY2013Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
57466000 | USD |
| CY2011Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
43422000 | USD |
| CY2012Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
37742000 | USD |
| CY2014 | us-gaap |
Stock Issued1
StockIssued1
|
USD | |
| CY2014 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
2596032 | shares |
| CY2012Q3 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
8000000 | shares |
| CY2014 | us-gaap |
Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
|
2500000 | shares |
| CY2014 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
15000 | shares |
| CY2013 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
1400000 | USD |
| CY2012 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
3672000 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
10644000 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
34106000 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
|
10414000 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
5851000 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
2799000 | USD |
| CY2012 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
4927000 | USD |
| CY2014 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> a.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Use of estimates</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> </div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates, judgments, and assumptions that are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</div> </td> </tr> </table> </div> <!--EndFragment--></div> </div> | |
| CY2014 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
63514405 | shares |
| CY2013 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
55481357 | shares |
| CY2012 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
44031866 | shares |
